Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124997086 | 12499708 | 6 | F | 20160613 | 20160906 | 20160627 | 20160916 | EXP | PHHO2016US008777 | SANDOZ | 65.13 | YR | F | Y | 72.60000 | KG | 20160916 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124997086 | 12499708 | 1 | SS | CANDESARTAN CILEXETIL. | CANDESARTAN CILEXETIL | 1 | Oral | 32 MG, QD | 0 | 32 | MG | QD | |||||||
| 124997086 | 12499708 | 2 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 160 MG, QD | 18569 | 160 | MG | QD | |||||||
| 124997086 | 12499708 | 3 | SS | ACZ885 | CANAKINUMAB | 1 | Subcutaneous | 0 | POWDER FOR SOL FOR INJ | ||||||||||
| 124997086 | 12499708 | 4 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 25 MG, QD | 0 | 25 | MG | QD | |||||||
| 124997086 | 12499708 | 5 | C | INSULIN LISPRO | INSULIN LISPRO | 1 | Subcutaneous | 25 U, QD | 0 | 25 | DF | QD | |||||||
| 124997086 | 12499708 | 6 | C | INSULIN GLARGINE | INSULIN GLARGINE | 1 | Subcutaneous | 30 U, QHS | 0 | 30 | DF | ||||||||
| 124997086 | 12499708 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, BID | 0 | 1000 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124997086 | 12499708 | 1 | Hypertension |
| 124997086 | 12499708 | 2 | Hypertension |
| 124997086 | 12499708 | 3 | Cardiovascular event prophylaxis |
| 124997086 | 12499708 | 4 | Hypertension |
| 124997086 | 12499708 | 5 | Type 2 diabetes mellitus |
| 124997086 | 12499708 | 6 | Type 2 diabetes mellitus |
| 124997086 | 12499708 | 7 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124997086 | 12499708 | OT |
| 124997086 | 12499708 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124997086 | 12499708 | Acute kidney injury | |
| 124997086 | 12499708 | Asthenia | |
| 124997086 | 12499708 | Conversion disorder | |
| 124997086 | 12499708 | Dehydration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124997086 | 12499708 | 1 | 201004 | 0 | ||
| 124997086 | 12499708 | 2 | 20121115 | 0 | ||
| 124997086 | 12499708 | 3 | 20111122 | 0 | ||
| 124997086 | 12499708 | 4 | 20150805 | 0 | ||
| 124997086 | 12499708 | 5 | 201004 | 0 | ||
| 124997086 | 12499708 | 6 | 201004 | 0 | ||
| 124997086 | 12499708 | 7 | 20131211 | 0 |